Dian Diagnostics Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	10,503	12,196	13,407	20,281	13,079	10,648
Other Revenue	0.37	0.37	1.36	1.71	3.6	1.66
Revenue	10,504	12,196	13,408	20,282	13,083	10,649
Revenue Growth (YoY)	-15.12%	-9.04%	-33.89%	55.03%	22.85%	25.98%
Cost of Revenue	7,516	8,811	9,256	12,809	8,100	6,596
Gross Profit	2,987	3,385	4,152	7,473	4,983	4,053
Selling, General & Admin	1,974	2,049	2,300	2,834	2,296	1,715
Research & Development	250.07	305.88	432.64	638.47	424.75	319.1
Other Operating Expenses	43.91	39.36	30.44	56.17	44.65	36.85
Operating Expenses	2,676	2,839	3,139	3,817	2,856	2,151
Operating Income	311.73	546.34	1,013	3,657	2,127	1,902
Interest Expense	-156.59	-203.03	-250.6	-274.73	-230.2	-206.82
Interest & Investment Income	72.28	64.38	41.76	69.62	77.47	92.6
Currency Exchange Gain (Loss)	-2.02	-2.02	0.84	-25.12	-2.33	2.62
Other Non Operating Income (Expenses)	-27.52	-35.57	-24.48	-38.46	-15.49	-25.17
EBT Excluding Unusual Items	197.89	370.11	780.65	3,388	1,956	1,766
Impairment of Goodwill	-377.97	-377.97	-	-589.64	-	-445.74
Gain (Loss) on Sale of Investments	-1.42	-28.72	-18.32	-56.24	-187.72	-31.45
Gain (Loss) on Sale of Assets	-4.59	-1.48	-3.57	-11.18	6.35	-0.08
Asset Writedown	-13.19	-13.14	-25.72	-242.16	-21.53	-2.12
Legal Settlements	-	-	-	-	-7.59	-
Other Unusual Items	-0.63	-0.63	65.29	54.74	45.1	31.18
Pretax Income	-199.91	-51.83	798.33	2,544	1,791	1,317
Income Tax Expense	90	117.41	216.74	681.09	307.4	247.46
Earnings From Continuing Operations	-289.91	-169.23	581.59	1,862	1,484	1,070
Minority Interest in Earnings	-141.52	-188.04	-274.13	-428.28	-320.72	-267
Net Income	-431.43	-357.28	307.46	1,434	1,163	802.93
Net Income to Common	-431.43	-357.28	307.46	1,434	1,163	802.93
Net Income Growth	-	-	-78.56%	23.33%	44.83%	131.20%
Shares Outstanding (Basic)	612	617	625	623	620	620
Shares Outstanding (Diluted)	612	617	625	624	624	622
Shares Change (YoY)	-1.03%	-1.30%	0.18%	-0.02%	0.43%	0.22%
EPS (Basic)	-0.70	-0.58	0.49	2.30	1.87	1.29
EPS (Diluted)	-0.70	-0.58	0.49	2.30	1.86	1.29
EPS Growth	-	-	-78.60%	23.36%	44.21%	130.70%
Free Cash Flow	1,671	844.2	1,220	691.64	728.42	1,072
Free Cash Flow Per Share	2.73	1.37	1.95	1.11	1.17	1.72
Dividend Per Share	0.250	0.900	0.060	0.200	0.135	0.130
Dividend Growth	-64.79%	1400.00%	-70.00%	48.15%	3.85%	1.56%
Gross Margin	28.44%	27.75%	30.97%	36.85%	38.09%	38.06%
Operating Margin	2.97%	4.48%	7.56%	18.03%	16.26%	17.86%
Profit Margin	-4.11%	-2.93%	2.29%	7.07%	8.89%	7.54%
Free Cash Flow Margin	15.91%	6.92%	9.10%	3.41%	5.57%	10.06%
EBITDA	639.96	928.27	1,467	4,247	2,468	2,195
EBITDA Margin	6.09%	7.61%	10.94%	20.94%	18.87%	20.61%
D&A For EBITDA	328.23	381.92	453.51	590.21	341.57	292.91
EBIT	311.73	546.34	1,013	3,657	2,127	1,902
EBIT Margin	2.97%	4.48%	7.56%	18.03%	16.26%	17.86%
Effective Tax Rate	-	-	27.15%	26.78%	17.16%	18.78%
Revenue as Reported	10,504	12,196	13,408	20,282	13,083	10,649
Advertising Expenses	-	59.27	68.34	76.59	59.74	61.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.